Skip to content
Annalist
Companies Compare Method Data Quality For AI agents

Amgen Inc.

AMGN · Nasdaq · Health care, biotechnology · United States · US GAAP · Fiscal year ends December

Latest report: Q2 FY2026, the quarter ended 30 June 2026, released 5 August 2026. Snapshot FY2026Q2_3ae3015b.

Overview

Revenue, quarter
+9.5% year on year
Operating income, quarter
+32.3% year on year
Net income, quarter
+65.9% year on year
Diluted EPS, quarter
+64.9% year on year
Operating margin, last 4 quarters
+6.5pp year on year
Return on equity, last 4 quarters
−7.7pp year on year

Select a figure to see the document it came from.

Key Findings

Findings for the latest quarter, with their history over earlier quarters.

  1. Revenue for the quarter ended 30 June 2026 was US$10.1 billion, 9.5% higher than in the same quarter a year earlier.

    Strengthenedin Q2 FY2026 · stated since Q2 FY2024
    Rule: Revenue against a year earlier · Sources 10-Q 2026-06
    History of this finding, 9 records
    1. Q2 FY2026 StrengthenedRevenue for the quarter ended 30 June 2026 was US$10.1 billion, 9.5% higher than in the same quarter a year earlier.Recorded from FY2026Q2_7aabc64d · data update
    2. Q1 FY2026 WeakenedRevenue for the quarter ended 31 March 2026 was US$8.6 billion, 5.8% higher than in the same quarter a year earlier.Reconstructed · data update
    3. Q4 FY2025 WeakenedRevenue for the quarter ended 31 December 2025 was US$9.9 billion, 8.6% higher than in the same quarter a year earlier.Reconstructed · data update
    4. Q3 FY2025 StrengthenedRevenue for the quarter ended 30 September 2025 was US$9.6 billion, 12.4% higher than in the same quarter a year earlier.Reconstructed · data update
    5. Q2 FY2025 ConfirmedRevenue for the quarter ended 30 June 2025 was US$9.2 billion, 9.4% higher than in the same quarter a year earlier.Reconstructed · data update
    6. Q1 FY2025 WeakenedRevenue for the quarter ended 31 March 2025 was US$8.1 billion, 9.4% higher than in the same quarter a year earlier.Reconstructed · data update
    7. Q4 FY2024 WeakenedRevenue for the quarter ended 31 December 2024 was US$9.1 billion, 10.9% higher than in the same quarter a year earlier.Reconstructed · data update
    8. Q3 FY2024 StrengthenedRevenue for the quarter ended 30 September 2024 was US$8.5 billion, 23.2% higher than in the same quarter a year earlier.Reconstructed · data update
    9. Q2 FY2024 NewRevenue for the quarter ended 30 June 2024 was US$8.4 billion, 20.1% higher than in the same quarter a year earlier.Reconstructed · initial
  2. Net income attributable to the company was US$2.4 billion, 65.9% higher than in the same quarter a year earlier.

    Strengthenedin Q2 FY2026 · stated since Q2 FY2025
    Rule: Net income against a year earlier · Sources 10-Q 2026-06
    History of this finding, 13 records
    1. Q2 FY2026 StrengthenedNet income attributable to the company was US$2.4 billion, 65.9% higher than in the same quarter a year earlier.Recorded from FY2026Q2_7aabc64d · data update
    2. Q1 FY2026 WeakenedNet income attributable to the company was US$1.8 billion, 5.1% higher than in the same quarter a year earlier.Reconstructed · data update
    3. Q4 FY2025 StrengthenedNet income attributable to the company was US$1.3 billion, 112.6% higher than in the same quarter a year earlier.Reconstructed · data update
    4. Q3 FY2025 WeakenedNet income attributable to the company was US$3.2 billion, 13.6% higher than in the same quarter a year earlier.Reconstructed · data update
    5. Q2 FY2025 NewNet income attributable to the company was US$1.4 billion, 92.0% higher than in the same quarter a year earlier.Reconstructed · data update
    6. Q2 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    7. Q1 FY2025 NewNet income attributable to the company was US$1.7 billion, against a net loss of US$113 million in the same quarter a year earlier.Reconstructed · data update
    8. Q1 FY2025 RetiredThe finding changed to a profit after a loss a year earlier.Reconstructed · data update
    9. Q4 FY2024 NewNet income attributable to the company was US$627 million, 18.3% lower than in the same quarter a year earlier.Reconstructed · data update
    10. Q4 FY2024 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    11. Q3 FY2024 NewNet income attributable to the company was US$2.8 billion, 63.6% higher than in the same quarter a year earlier.Reconstructed · data update
    12. Q3 FY2024 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    13. Q2 FY2024 NewNet income attributable to the company was US$746 million, 45.9% lower than in the same quarter a year earlier.Reconstructed · initial
  3. The operating margin over the last 4 quarters was 30.0%, 6.5 percentage points higher than a year earlier.

    Confirmedin Q2 FY2026 · stated since Q2 FY2025
    Rule: Operating margin against a year earlier · Sources 10-Q 2025-09, 10-K 2025-12, 10-Q 2026-03 and 1 more
    History of this finding, 10 records
    1. Q2 FY2026 ConfirmedThe operating margin over the last 4 quarters was 30.0%, 6.5 percentage points higher than a year earlier.Recorded from FY2026Q2_7aabc64d · data update
    2. Q1 FY2026 StrengthenedThe operating margin over the last 4 quarters was 28.4%, 6.6 percentage points higher than a year earlier.Reconstructed · data update
    3. Q4 FY2025 WeakenedThe operating margin over the last 4 quarters was 24.7%, 3.0 percentage points higher than a year earlier.Reconstructed · data update
    4. Q3 FY2025 StrengthenedThe operating margin over the last 4 quarters was 24.1%, 5.0 percentage points higher than a year earlier.Reconstructed · data update
    5. Q2 FY2025 NewThe operating margin over the last 4 quarters was 23.5%, 3.4 percentage points higher than a year earlier.Reconstructed · data update
    6. Q2 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    7. Q1 FY2025 WeakenedThe operating margin over the last 4 quarters was 21.8%, 1.8 percentage points lower than a year earlier.Reconstructed · data update
    8. Q4 FY2024 WeakenedThe operating margin over the last 4 quarters was 21.7%, 6.3 percentage points lower than a year earlier.Reconstructed · data update
    9. Q3 FY2024 WeakenedThe operating margin over the last 4 quarters was 19.1%, 13.9 percentage points lower than a year earlier.Reconstructed · data update
    10. Q2 FY2024 NewThe operating margin over the last 4 quarters was 20.0%, 15.7 percentage points lower than a year earlier.Reconstructed · initial
  4. Return on equity over the last 4 quarters was 91.5%, against 99.1% a year earlier.

    Strengthenedin Q2 FY2026 · stated since Q1 FY2026
    Rule: Return on equity against a year earlier · Sources 10-Q 2025-06, 10-Q 2026-06, 10-Q 2025-09 and 3 more
    History of this finding, 11 records
    1. Q2 FY2026 StrengthenedReturn on equity over the last 4 quarters was 91.5%, against 99.1% a year earlier.Recorded from FY2026Q2_7aabc64d · data update
    2. Q1 FY2026 NewReturn on equity over the last 4 quarters was 101.3%, against 105.7% a year earlier.Reconstructed · data update
    3. Q1 FY2026 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    4. Q4 FY2025 StrengthenedReturn on equity over the last 4 quarters was 106.1%, against 67.6% a year earlier.Reconstructed · data update
    5. Q3 FY2025 WeakenedReturn on equity over the last 4 quarters was 81.7%, against 55.7% a year earlier.Reconstructed · data update
    6. Q2 FY2025 StrengthenedReturn on equity over the last 4 quarters was 99.1%, against 49.3% a year earlier.Reconstructed · data update
    7. Q1 FY2025 NewReturn on equity over the last 4 quarters was 105.7%, against 72.6% a year earlier.Reconstructed · data update
    8. Q1 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    9. Q4 FY2024 WeakenedReturn on equity over the last 4 quarters was 67.6%, against 135.8% a year earlier.Reconstructed · data update
    10. Q3 FY2024 WeakenedReturn on equity over the last 4 quarters was 55.7%, against 133.8% a year earlier.Reconstructed · data update
    11. Q2 FY2024 NewReturn on equity over the last 4 quarters was 49.3%, against 173.5% a year earlier.Reconstructed · initial
  5. Free cash flow over the last 4 quarters was US$10.2 billion, and operating cash flow was 1.4 times net income attributable to the company.

    Interpretation. Operating cash flow paid for all capital expenditure, and the rest is free for dividends, share buybacks or debt repayment.

    Strengthenedin Q2 FY2026 · stated since Q2 FY2024
    Rule: Free cash flow · Sources 10-Q 2025-06, 10-Q 2025-09, 10-K 2025-12 and 2 more
    History of this finding, 9 records
    1. Q2 FY2026 StrengthenedFree cash flow over the last 4 quarters was US$10.2 billion, and operating cash flow was 1.4 times net income attributable to the company.Recorded from FY2026Q2_7aabc64d · data update
    2. Q1 FY2026 StrengthenedFree cash flow over the last 4 quarters was US$8.6 billion, and operating cash flow was 1.4 times net income attributable to the company.Reconstructed · data update
    3. Q4 FY2025 WeakenedFree cash flow over the last 4 quarters was US$8.1 billion, and operating cash flow was 1.3 times net income attributable to the company.Reconstructed · data update
    4. Q3 FY2025 StrengthenedFree cash flow over the last 4 quarters was US$11.5 billion, and operating cash flow was 1.9 times net income attributable to the company.Reconstructed · data update
    5. Q2 FY2025 ConfirmedFree cash flow over the last 4 quarters was US$10.6 billion, and operating cash flow was 1.8 times net income attributable to the company.Reconstructed · data update
    6. Q1 FY2025 StrengthenedFree cash flow over the last 4 quarters was US$10.9 billion, and operating cash flow was 2.1 times net income attributable to the company.Reconstructed · data update
    7. Q4 FY2024 StrengthenedFree cash flow over the last 4 quarters was US$10.4 billion, and operating cash flow was 2.8 times net income attributable to the company.Reconstructed · data update
    8. Q3 FY2024 StrengthenedFree cash flow over the last 4 quarters was US$6.3 billion, and operating cash flow was 1.7 times net income attributable to the company.Reconstructed · data update
    9. Q2 FY2024 NewFree cash flow over the last 4 quarters was US$5.5 billion, and operating cash flow was 2.1 times net income attributable to the company.Reconstructed · initial
  6. Net debt was US$43.3 billion at 30 June 2026, 2.7 times EBITDA over the last 4 quarters.

    Confirmedin Q2 FY2026 · stated since Q2 FY2024
    Rule: Net debt or net cash · Sources 10-Q 2026-06, 10-Q 2025-06, 10-Q 2025-09 and 2 more
    History of this finding, 10 records
    1. Q2 FY2026 ConfirmedNet debt was US$43.3 billion at 30 June 2026, 2.7 times EBITDA over the last 4 quarters.Recorded from FY2026Q2_34d85ef7 · correction
    2. Q2 FY2026 ConfirmedNet debt was US$43.3 billion at 30 June 2026, 3.1 times EBITDA over the last 4 quarters.Recorded from FY2026Q2_7aabc64d · data update
    3. Q1 FY2026 ConfirmedNet debt was US$45.3 billion at 31 March 2026, 3.4 times EBITDA over the last 4 quarters.Reconstructed · data update
    4. Q4 FY2025 ConfirmedNet debt was US$45.5 billion at 31 December 2025, 3.8 times EBITDA over the last 4 quarters.Reconstructed · data update
    5. Q3 FY2025 WeakenedNet debt was US$45.1 billion at 30 September 2025, 3.8 times EBITDA over the last 4 quarters.Reconstructed · data update
    6. Q2 FY2025 ConfirmedNet debt was US$48.2 billion at 30 June 2025, 4.2 times EBITDA over the last 4 quarters.Reconstructed · data update
    7. Q1 FY2025 ConfirmedNet debt was US$48.6 billion at 31 March 2025, 4.6 times EBITDA over the last 4 quarters.Reconstructed · data update
    8. Q4 FY2024 WeakenedNet debt was US$48.1 billion at 31 December 2024, 4.6 times EBITDA over the last 4 quarters.Reconstructed · data update
    9. Q3 FY2024 ConfirmedNet debt was US$51.4 billion at 30 September 2024, 5.5 times EBITDA over the last 4 quarters.Reconstructed · data update
    10. Q2 FY2024 NewNet debt was US$53.3 billion at 30 June 2024, 5.3 times EBITDA over the last 4 quarters.Reconstructed · initial

Records before Q2 FY2026 are reconstructed from the latest snapshot. Ledger: findings.json. Correction of 20 October 2026: The quarterly depreciation and amortisation of Amgen mixed the total of its cash flow statement with a narrower line: US$202 million for the second quarter of 2024 beside US$1,399 million for the first. Every quarter now comes from the cash flow statement, US$1,400 million for that second quarter. Its 10-Qs give the dividend per share of a quarter for their cumulative periods as well, and its 10-Ks give the dividends of the year. 6 dividends per share of second quarters that the set of filings of their quarter does not report, and 1 derived from 2 filings, are no longer published. 4 fourth quarters now show the dividend that their set of filings reports, 2.38 for 2025 where 2.52 was published. 4 negative quarterly proceeds of debt are withheld. Records 100 and 101 state the corrected findings. Records 6, 19, 28, 43, 53, 61, 69, 84, 92 and 98 cite figures that the correction changed.

Credit, liquidity, earnings quality and score findings: Analysis.

Data

Source documents28 documents, latest Form 10-Q, period ended 30 June 2026List
DownloadsExcel workbook · JSON
SnapshotFY2026Q2_3ae3015b

Corporate Events

  1. Acquisitions paid in cash31 December 2023

    Paid US$27.0 billion in cash for business acquisitions in fiscal 2023, 41.4% of total assets at the start of the year.

    Source 10-K 2025-12
  2. Acquisition or disposal6 October 2023

    Completed an acquisition or disposition of assets.

    Source 8-K 2023-10
  3. Acquisitions paid in cash31 December 2022

    Paid US$3.8 billion in cash for business acquisitions in fiscal 2022, 6.3% of total assets at the start of the year.

    Source 10-K 2024-12
  4. Acquisition16 April 2021

    Completed an acquisition.

    Source 8-K 2021-04

Earnings, Returns and Balance Sheet

Revenue

By quarter, US dollars

Operating Income

By quarter, US dollars

Net Income Attributable to the Company

By quarter, US dollars

Margins

Last 4 quarters at each quarter end, per cent

Returns

Last 4 quarters, per cent

Free Cash Flow

Operating cash flow less capital expenditure, by quarter, US dollars

Net Debt

Total debt less cash and short-term investments, at quarter end, US dollars

Diluted Earnings per Share

By quarter, as reported

Financial Statements

Figures as filed. Select a figure for its source document and method; a small d marks a quarter derived from cumulative reports.

The statements are loading. They are also available as JSON and CSV.

Ratios

Select a ratio for its formula and the figures it uses, each with its document; (i) gives its definition.

The ratios are loading.

Source Documents

Documents of this snapshot, latest first.

DocumentDateId
Form 10-Q, period ended 30 June 20265 Aug 202610-Q:0000318154-26-000126
Form 10-Q, period ended 31 March 20261 May 202610-Q:0000318154-26-000057
Form 10-K, period ended 31 December 202513 Feb 202610-K:0000318154-26-000010
Form 10-Q, period ended 30 September 20255 Nov 202510-Q:0000318154-25-000072
Form 10-Q, period ended 30 June 20256 Aug 202510-Q:0000318154-25-000056
Form 10-Q, period ended 31 March 20252 May 202510-Q:0000318154-25-000020
Form 10-K, period ended 31 December 202414 Feb 202510-K:0000318154-25-000010
Form 10-Q, period ended 30 September 202431 Oct 202410-Q:0000318154-24-000044
Form 10-Q, period ended 30 June 20247 Aug 202410-Q:0000318154-24-000035
Form 10-Q, period ended 31 March 20243 May 202410-Q:0000318154-24-000020
Form 10-K, period ended 31 December 202314 Feb 202410-K:0000318154-24-000011
Form 10-Q, period ended 30 September 202331 Oct 202310-Q:0000318154-23-000064
Form 8-K, period ended 6 October 20236 Oct 20238-K:0001193125-23-252361
Form 10-Q, period ended 30 June 20234 Aug 202310-Q:0000318154-23-000053
Form 10-Q, period ended 31 March 202328 Apr 202310-Q:0000318154-23-000029
Form 10-K, period ended 31 December 20229 Feb 202310-K:0000318154-23-000017
Form 10-Q, period ended 30 September 20224 Nov 202210-Q:0000318154-22-000055
Form 10-Q, period ended 30 June 20225 Aug 202210-Q:0000318154-22-000041
Form 10-Q, period ended 31 March 202228 Apr 202210-Q:0000318154-22-000021
Form 10-K, period ended 31 December 202116 Feb 202210-K:0000318154-22-000010
Form 10-Q, period ended 30 September 20213 Nov 202110-Q:0000318154-21-000045
Form 10-Q, period ended 30 June 20214 Aug 202110-Q:0000318154-21-000034
Form 10-Q, period ended 31 March 202128 Apr 202110-Q:0000318154-21-000019
Form 8-K, period ended 16 April 202116 Apr 20218-K:0001193125-21-118557
Form 10-K, period ended 31 December 20209 Feb 202110-K:0000318154-21-000010
Form 10-Q, period ended 30 September 202029 Oct 202010-Q:0000318154-20-000060
Form 10-Q, period ended 30 June 202029 Jul 202010-Q:0000318154-20-000048
Form 10-Q, period ended 31 March 20201 May 202010-Q:0000318154-20-000031

Checks

265256 of 265 checks passed, 9 warnings
Fiscal calendar68 passedFiscal years last 350 to 380 days, quarters 80 to 125 days, and each period starts on the day after the one before. Checked at error level.
Quarters and fiscal year128 passedThe 4 quarters of every item add up to its fiscal year, or a later filing restated the year. Checked at error level.
Reported quarters0 of 4 passedA quarter that a filing reports on its own agrees with the figures of the same filing. Checked at warning level.
Amortisation of intangible assets, Q3 FY2020: $708m against $700m
Amortisation of intangible assets, Q3 FY2021: $642m against $600m
Amortisation of intangible assets, Q3 FY2022: $628m against $600m
Amortisation of intangible assets, Q3 FY2023: $693m against $700m
Withheld values4 values withheldA value that contradicts the definition of its item, or that documents report in contradiction, is withheld. Checked at warning level.
Proceeds from issuance of long-term debt, Q3 FY2020: withheld, negative where the item cannot be negative
Proceeds from issuance of long-term debt, Q4 FY2021: withheld, negative where the item cannot be negative
Proceeds from issuance of long-term debt, Q4 FY2022: withheld, negative where the item cannot be negative
Proceeds from issuance of long-term debt, Q2 FY2023: withheld, negative where the item cannot be negative
Filer identity1 passedThe documents are those of the company of this page. Checked at error level.
Balance sheet identity26 passedTotal assets equal total liabilities and equity at each balance sheet date. Checked at error level.
Lease liabilities6 passedLease payments due, less imputed interest, equal the lease liabilities. Checked at warning level.
Debt maturities6 passedThe debt maturity schedule adds up to the long-term debt. Checked at warning level.
Quarters and 9 months15 passedThe 3 reported quarters of a fiscal year add up to the reported 9-month figure. Checked at error level.
Gross profit0 of 1 passedRevenue less cost of revenue equals reported gross profit. Checked at warning level.
Q4 FY2020: 5,037,000,000 against 4,737,000,000
Earnings per share6 passedNet income divided by average shares agrees with reported basic earnings per share. Checked at warning level.

Data Quality

How many values of this snapshot the checks prove, and how many Annalist derives, withholds and tracks as restated. Every company.

Values published1,390
Proven by a check49.8%, 692 values
Confirmed by a second document0.0%, 0 values
Derived from reported figures21.1%, 293 values
Values withheld4
Restated figures tracked3
Changes compared on one basis0
Company lines mapped0 of 0 reviewed

Citation

Annalist, Amgen Inc., snapshot amgen/FY2026Q2_3ae3015b (as of FY2026 Q2); <item label>, <period>; source <document id> (<document url>)

Snapshot FY2026Q2_3ae3015b · dataset SHA-256 3ae3015b089094fba085dc15130f59c207c864517389b0ad0d585b0d9de38d7c · findings rules 0.4

Data: info.json · dataset.json · validation.json · documents.json